Investors & partners

A wound-focused topical nitric oxide development program.

NOxy combines patented point-of-care foam generation, the NOX1416 clinical program, peer-reviewed laboratory and real-world research, and a team with wound-care, clinical, scientific, engineering, and operating experience.

Program foundation

What supports the NOxy program.

Nitric oxide biology

Published literature describes nitric oxide across signaling, immune response, microbial burden, and tissue repair.

Point-of-care foam

Two components combine as a topical foam and generate nitric oxide at application.

Evidence by study type

Clinical development, retrospective analysis, tissue models, laboratory assays, and reviews are reported separately.

Wound-care execution

The team brings wound-care, clinical, scientific, engineering, and operating experience.

Partnering

Investment, development, and research partnerships.

NOxy welcomes conversations with investors, strategic partners, clinical researchers, and organizations working on hard-to-heal wounds.

Connect with NOxy

Identify your area of interest so we can route your inquiry to the appropriate NOxy team member.

Contact the team